Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 13Pancreatic Cyst 3Lung Neoplasms 3Esophageal Neoplasms 2Pancreatitis, Chronic 1Pancreatic adenoma 1Lymphadenopathy 1Jaundice 1Gastrointestinal Neoplasms 1Esophagus 1Cysts 1Colorectal Neoplasms 1Cholestasis 1Arachnodactyly 1Adrenal Gland Neoplasms 1Adrenal Gland Diseases 1Adenoma, Islet Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 90Fluorouracil 76Radiotherapy 63Paclitaxel 58Docetaxel 49Oxaliplatin 48Irinotecan 42Leucovorin 32Capecitabine 31Carboplatin 27Radiation 21Surgical Procedures, Operative 20Esophagectomy 20pembrolizumab 15Neoadjuvant Therapy 15Bevacizumab 15Cetuximab 13Drug Therapy 12Epirubicin 11Chemotherapy, Adjuvant 9S 1 (combination) 8Magnetic Resonance Spectroscopy 8Gemcitabine 8Trastuzumab 7Nivolumab 7Erlotinib Hydrochloride 7Surveys and Questionnaires 6Panitumumab 6Immunohistochemistry 6Chemoradiotherapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Esophageal Neoplasms × Endoscopic Ultrasound-Guided Fine Needle Aspiration × Clear all
NCT02372929 2025-11-12

ESOCA

AdventHealth

Completed
100 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01038544 2012-06-22

CT0003

Centre hospitalier de l'Université de Montréal (CHUM)

Phase NA Completed
50 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡